These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 3291258)

  • 21. Renal function and blood pressure in heart transplant recipients treated with cyclosporine.
    Rottembourg J; Mattei MF; Cabrol A; Leger P; Aupetit B; Beaufils H; Gluckman JC; Pavie A; Gandjbakhch I; Cabrol C
    J Heart Transplant; 1985; 4(4):404-8. PubMed ID: 3916515
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The value of serial serum trough cyclosporine levels in human renal transplantation.
    Kahan BD; Wideman CA; Reid M; Gibbons S; Jarowenko M; Flechner S; Van Buren CT
    Transplant Proc; 1984 Oct; 16(5):1195-9. PubMed ID: 6385376
    [No Abstract]   [Full Text] [Related]  

  • 23. A comparison of the clinical, histopathologic, cytologic, and biochemical features of renal transplant rejection, cyclosporine A nephrotoxicity, and stable renal function.
    Taube D; Neild G; Hobby P; Holt D; Welsh K; Cameron JS
    Transplant Proc; 1985 Aug; 17(4 Suppl 1):179-84. PubMed ID: 3895658
    [No Abstract]   [Full Text] [Related]  

  • 24. The use of low-dose cyclosporine A in combination with azathioprine and steroids in renal transplantation.
    Slapak M; Geoghegan T; Digard N; Ahmed K; Sharman VL; Crockett R
    Transplant Proc; 1987 Apr; 19(2 Suppl 2):41-5. PubMed ID: 3551255
    [No Abstract]   [Full Text] [Related]  

  • 25. Prevention of toxic side effects of cyclosporine in heart transplantation.
    Schüler S; Warnecke H; Hetzer R
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2518-21. PubMed ID: 3547936
    [No Abstract]   [Full Text] [Related]  

  • 26. Erythromycin and cyclosporine.
    Gonwa TA; Nghiem DD; Schulak JA; Corry RJ
    Transplantation; 1986 Jun; 41(6):797-9. PubMed ID: 3520996
    [No Abstract]   [Full Text] [Related]  

  • 27. Magnesium in cyclosporin-treated kidney transplant patients.
    Kaiser W
    Nephrol Dial Transplant; 1991; 6(5):374. PubMed ID: 1870756
    [No Abstract]   [Full Text] [Related]  

  • 28. Prediction of interpatient and intrapatient variation in OG 37-325 dosing requirements by the erythromycin breath test. A prospective study in renal transplant recipients.
    Turgeon DK; Leichtman AB; Blake DS; Schmouder RL; Lown KS; Annesley TM; Watkins PB
    Transplantation; 1994 Jun; 57(12):1736-41. PubMed ID: 8016878
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Pharmacokinetics of cyclosporin A and the significance of blood levels for therapy].
    Wonigeit K
    Internist (Berl); 1985 Sep; 26(9):534-41. PubMed ID: 3905673
    [No Abstract]   [Full Text] [Related]  

  • 30. Correlation of increased serum calcium fractions with the onset of cyclosporine-associated hypertension in renal transplant patients.
    Buscemi G; Giannetto V; Vaccaro F; Locascio G; Picone FP; Bellavia C; Romano M; Rapisarda LM
    Transplant Proc; 1987 Oct; 19(5):4003-4. PubMed ID: 3313984
    [No Abstract]   [Full Text] [Related]  

  • 31. Neurologic abnormalities and mortality in rats treated with cyclosporine A.
    Racusen LC; Famiglio LM; Fivush BA; Olton DS; Solez K
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):934-6. PubMed ID: 3388526
    [No Abstract]   [Full Text] [Related]  

  • 32. The effect of low-dose cyclosporine A on histopathologic findings in transplant biopsy specimens and function rates after cadaver renal transplantation.
    Niebel W; Metz K; Donhuijsen D; Albrecht KH; Windeck R; Eigler FW
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1772-5. PubMed ID: 3547882
    [No Abstract]   [Full Text] [Related]  

  • 33. Cyclosporine measurement in transplantation.
    Sanghvi A; Seltman H; Diven W
    Arch Pathol Lab Med; 1985 Dec; 109(12):1072-5. PubMed ID: 3907588
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of the calcium channel blocker diltiazem on cyclosporine A blood levels and dose requirements.
    Kohlhaw K; Wonigeit K; Frei U; Oldhafer K; Neumann K; Pichlmayr R
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):572-4. PubMed ID: 3284105
    [No Abstract]   [Full Text] [Related]  

  • 35. Cyclosporine blood level monitoring: the early posttransplant period.
    Ferguson RM; Canafax DM; Sawchuck RT; Simmons RL
    Transplant Proc; 1986 Apr; 18(2 Suppl 1):113-22. PubMed ID: 3515676
    [No Abstract]   [Full Text] [Related]  

  • 36. Cyclosporine in living related and cadaveric renal transplantation.
    Albrechtsen D; Soedal G; Berg KJ; Bondevik H; Brekke IB; Fauchald P; Jakobsen A; Opedal BR; Rugstad HE; Thorsby E
    Transplant Proc; 1984 Oct; 16(5):1191-4. PubMed ID: 6385375
    [No Abstract]   [Full Text] [Related]  

  • 37. Cyclosporine-induced nephrotoxicity in patients with autoimmune uveitis.
    Palestine AG; Austin HA; Nussenblatt RB
    Transplant Proc; 1985 Aug; 17(4 Suppl 1):209-14. PubMed ID: 3927536
    [No Abstract]   [Full Text] [Related]  

  • 38. Pneumatosis cystoides intestinalis with pneumoperitoneum in renal transplant patients on cyclosporine and prednisone.
    Ammons MA; Bauling PC; Weil R
    Transplant Proc; 1986 Dec; 18(6):1868-70. PubMed ID: 3538558
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cyclosporine nephrotoxicity can be minimized by careful monitoring of whole blood trough levels.
    Uchida K; Nakanisi N; Yamada N; Tominaga Y; Orihara A; Kondo T; Morimoto T; Morozumi K; Kano T; Takagi H
    Dev Toxicol Environ Sci; 1986; 14():163-6. PubMed ID: 3549249
    [No Abstract]   [Full Text] [Related]  

  • 40. Association between cyclosporin neurotoxicity and hypomagnesaemia.
    Thompson CB; June CH; Sullivan KM; Thomas ED
    Lancet; 1984 Nov; 2(8412):1116-20. PubMed ID: 6150182
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.